XERS - Xeris Pharmaceuticals GAAP EPS of -$0.19 beats by $0.04 revenue of $25.31M misses by $0.22M
- Xeris Pharmaceuticals press release ( NASDAQ: XERS ): Q2 GAAP EPS of -$0.19 beats by $0.04 .
- Revenue of $25.31M (+184.1% Y/Y) misses by $0.22M .
- Ended Q2 with $111.6M in cash, cash equivalents and short-term investments
For further details see:
Xeris Pharmaceuticals GAAP EPS of -$0.19 beats by $0.04, revenue of $25.31M misses by $0.22M